Professor Eric Moses - Centre Director
Professor Eric Moses (MSc, PhD) is a genetic epidemiologist and Director of the Centre for Genetic Origins of Health and Disease (GOHaD). He currently holds joint appointments as Professor at School of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Western Australia, as well as Professor at the School of Biomedical Sciences, Faculty of Health Sciences, Curtin University and is supported by the RPH Medical Research Foundation.
From 2005 to 2011, Prof Moses was Head of the Complex Disease Genetics Laboratory at the Texas Biomedical Research Institute in San Antonio, Texas where he led a major research program on the genetics of preeclampsia and cardiovascular disease funded by the US National Institutes of Health.
Since returning to Australia, Prof Moses has established a portfolio of collaborative research on the genetics of a number of complex human diseases posing a major health burden globally. These include cardiovascular/cardiometabolic disease, common pregnancy disorders, schizophrenia and several cancers. He has collaborated and published extensively on the genetic dissection of a variety of common complex human traits and conditions using contemporary high-throughput integrative genomics strategies in large population and family-based study designs.
Eric is also involved in the development of bioinformatics tools for the analysis of large genomic and other ‘omic’ datasets involving supercomputing capabilities in Melbourne and Perth. He sits on the Busselton Population Medical Research Institute Board and is a member of the Scientific Advisory Committee of the Royal Perth Hospital Medical Research Foundation Inc.
- Genetic epidemiology
- Molecular biology
- Molecular genetics
- Statistical genetics
- Analysing the genetic architecture of complex traits using longitudinal data
- Epigenetic modifications of complex disease over the human life course
- Genetics of isolated human populations
- The Busselton Family Heart Study
- Genetic biomarkers for congenital heart disease
- Genetic analysis of endophenotypes for schizophrenia
- Schizophrenia under the genomic lens
- Identification of protein altering variants influencing preeclampsia risk
- Epigenetic biomarkers for risk stratification of preeclampsia
- Integrative genomics of Vanin gene expression in relation to CVD risk
- Understanding the genetics of mesothelioma susceptibility and prognosis
- Integrating personalised genomic risk stratification models of population screening for cancer
- Prevalence, phenotype and genotype of common sleep disorders
Phone: +61(8) 9224 0349